Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Restraining PI3K: mTOR signalling goes back to the membrane

Thumbnail
Date
2005
ICR Author
Lamb, Richard
Author
Harrington, LS
Findlay, GM
Lamb, RF
Type
Journal Article
Metadata
Show full item record
Abstract
The lipid kinase phosphoinositide 3-kinase (PI3K) is activated in response to various extracellular signals including peptide growth factors such as insulin and insulin-like growth factors (IGFs). Phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] generated by PI3K is central to the diverse responses elicited by insulin, including glucose homeostasis, proliferation, survival and cell growth. The actions of lipid phosphatases have been considered to be the main means of attenuating PI3K signalling, whereby the principal 3-phosphatase – phosphatase and tensin homologue deleted on chromosome 10 (PTEN) – dephosphorylates PtdIns(3,4,5)P3, reversing the action of PI3K. Recently, however, another pathway of regulation of PI3K has been identified in which activation of PI3K itself is prevented. This finding, together with earlier work, strongly suggests that a major form of negative feedback inhibition of PI3K results from activated growth signalling via mammalian target of rapamycin (mTOR) and the p70 S6 kinase (S6K) – a pathway that could have consequences for the development of type 2 diabetes and tuberous sclerosis complex.
URI
https://repository.icr.ac.uk/handle/internal/2614
DOI
https://doi.org/10.1016/j.tibs.2004.11.003
Collections
  • Other ICR Research
Language
eng
License start date
2005
Citation
Trends in Biochemical Sciences, 2005, 30 pp. 35 - 42

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.